Medicare

Menu
Book Appointment
Edit Content
Book Appointment

Press list

CME: Molecular Cancer Diagnostics, Cancer Prevention, & The “Moonshot” Program
November 13, 2023

CME: Molecular Cancer Diagnostics, Cancer Prevention, & The “Moonshot” Program

CME: Molecular Cancer Diagnostics, Cancer Prevention, & The “Moonshot” Program
November 13, 2023

CME: Molecular Cancer Diagnostics, Cancer Prevention, & The “Moonshot” Program

CME: Molecular Cancer Diagnostics, Cancer Prevention, & The “Moonshot” Program
November 13, 2023

CME: Molecular Cancer Diagnostics, Cancer Prevention, & The “Moonshot” Program

CME: Molecular Cancer Diagnostics, Cancer Prevention, & The “Moonshot” Program
November 13, 2023

CME: Molecular Cancer Diagnostics, Cancer Prevention, & The “Moonshot” Program

CME: Molecular Cancer Diagnostics, Cancer Prevention, & The “Moonshot” Program
November 13, 2023

CME: Molecular Cancer Diagnostics, Cancer Prevention, & The “Moonshot” Program

CME: Molecular Cancer Diagnostics, Cancer Prevention, & The “Moonshot” Program
November 13, 2023

CME: Molecular Cancer Diagnostics, Cancer Prevention, & The “Moonshot” Program

CME: Molecular Cancer Diagnostics, Cancer Prevention, & The “Moonshot” Program
November 13, 2023

CME: Molecular Cancer Diagnostics, Cancer Prevention, & The “Moonshot” Program

CME: Molecular Cancer Diagnostics, Cancer Prevention, & The “Moonshot” Program Praava Health brings the first Molecular Cancer Diagnostics (PCR) lab in Bangladesh in certain cancers – breast, lung, cervical and colorectal. Dr. Zaheed Husain, Praava’s Senior Director, Cancer Diagnostics, spoke

CME: Molecular Cancer Diagnostics, Cancer Prevention, & The “Moonshot” Program
November 13, 2023

CME: Molecular Cancer Diagnostics, Cancer Prevention, & The “Moonshot” Program

CME: Molecular Cancer Diagnostics, Cancer Prevention, & The “Moonshot” Program Praava Health brings the first Molecular Cancer Diagnostics (PCR) lab in Bangladesh in certain cancers – breast, lung, cervical and colorectal. Dr. Zaheed Husain, Praava’s Senior Director, Cancer Diagnostics, spoke